UnitedHealth Group (NYSE: UNH) recently reported its Q3 results, with revenues and earnings exceeding our expectations.

I discuss and analyze UNH's cautious FY2025 guidance, attributing lower bottom-line to various factors. Click here to read my ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about ...

UnitedHealth earnings topped forecasts, but the Dow Jones member lowered the top end of its full-year outlook.

Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on UnitedHealth (UNH – Research Report) today and set a price target of ...

UnitedHealth's lower 2025 earnings outlook than expected leads to a sell-off, affecting its managed care rivals like ...

Shares of UnitedHealth Group tumbled Tuesday as the company lowered its full-year outlook to reflect the impact of a February ...

UNH, CI, HUM and MOH are likely to navigate industry ... that the majority of the unknowns have been cleared up, views the stock selloff as overdone, and would use it as an opportunity to buy ...

The UNH stock performance is affected by management’s full-year 2024 outlook of $15.50 to $15.75 per share in net income, ...

What Are The Key Trends To Drive UnitedHealth’s Q3 Results? UnitedHealth should continue to benefit from an increase in total ...

UNITEDHEALTH GROUP INC (UNH) is a large-cap growth stock in the Insurance (Accident & Health) industry. The rating using this strategy is 77% based on the firm’s underlying fundamentals and the ...